{"id":"https://openalex.org/W4386280355","doi":"https://doi.org/10.1016/j.rpth.2023.102194","title":"Neutralizing antidrug antibody to emicizumab in patients with severe hemophilia A: Case report of a first noninhibitor patient and review of the literature","display_name":"Neutralizing antidrug antibody to emicizumab in patients with severe hemophilia A: Case report of a first noninhibitor patient and review of the literature","publication_year":2023,"publication_date":"2023-08-01","ids":{"openalex":"https://openalex.org/W4386280355","doi":"https://doi.org/10.1016/j.rpth.2023.102194","pmid":"https://pubmed.ncbi.nlm.nih.gov/37732158","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10507376"},"language":"en","primary_location":{"id":"doi:10.1016/j.rpth.2023.102194","doi":"https://doi.org/10.1016/j.rpth.2023.102194","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rpth.2023.102194","pdf_url":null,"source":{"id":"https://openalex.org/S4210185368","display_name":"Research and Practice in Thrombosis and Haemostasis","issn_l":"2475-0379","issn":["2475-0379"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Research and Practice in Thrombosis and Haemostasis","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.rpth.2023.102194","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048561431","display_name":"Hande K\u0131z\u0131locak","orcid":"https://orcid.org/0000-0003-0323-2571","observed_orcids":["https://orcid.org/0000-0003-0323-2571"]},"institutions":[{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hande Kizilocak","raw_affiliation_strings":["Children's Hospital Los Angeles, Hemostasis and Thrombosis Center, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Hospital Los Angeles, Hemostasis and Thrombosis Center, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1336910626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109157696","display_name":"Michael F. Guerrera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1336742384","display_name":"Children's National","ror":"https://ror.org/03wa2q724","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336742384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael F. Guerrera","raw_affiliation_strings":["Children's National Hospital, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's National Hospital, Washington, DC, USA","institution_ids":["https://openalex.org/I1336742384"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004338432","display_name":"Guy A. Young","orcid":"https://orcid.org/0000-0001-6013-1254","observed_orcids":["https://orcid.org/0000-0001-6013-1254"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Guy Young","raw_affiliation_strings":["Children's Hospital Los Angeles, Hemostasis and Thrombosis Center, Los Angeles, CA, USA","University of Southern California, Keck School of Medicine, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Hospital Los Angeles, Hemostasis and Thrombosis Center, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1336910626"]},{"raw_affiliation_string":"University of Southern California, Keck School of Medicine, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1174212"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5004338432"],"corresponding_institution_ids":["https://openalex.org/I1174212","https://openalex.org/I1336910626"],"apc_list":{"value":2250,"currency":"USD","value_usd":2250},"apc_paid":{"value":2250,"currency":"USD","value_usd":2250},"fwci":2.2457,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.89107364,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"7","issue":"6","first_page":"102194","last_page":"102194"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/emicizumab","display_name":"emicizumab","score":0.9700000286102295},{"id":"https://openalex.org/keywords/hemophilia-a","display_name":"hemophilia A","score":0.9549999833106995},{"id":"https://openalex.org/keywords/factor-viii-inhibitors","display_name":"factor VIII inhibitors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/bleeding-complications","display_name":"bleeding complications","score":0.4790000021457672},{"id":"https://openalex.org/keywords/bethesda-assay","display_name":"Bethesda assay","score":0.7599999904632568},{"id":"https://openalex.org/keywords/drug-immunogenicity","display_name":"drug immunogenicity","score":0.6420000195503235},{"id":"https://openalex.org/keywords/coagulation-factor-concentrates","display_name":"coagulation factor concentrates","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.7152130603790283},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6692947149276733},{"id":"https://openalex.org/C2778261982","wikidata":"https://www.wikidata.org/wiki/Q1755136","display_name":"Partial thromboplastin time","level":3,"score":0.5773645639419556},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.519360363483429},{"id":"https://openalex.org/C144594695","wikidata":"https://www.wikidata.org/wiki/Q6153218","display_name":"Thromboplastin","level":3,"score":0.44082680344581604},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.4224318265914917},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3652784526348114},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3250734508037567}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1016/j.rpth.2023.102194","doi":"https://doi.org/10.1016/j.rpth.2023.102194","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rpth.2023.102194","pdf_url":null,"source":{"id":"https://openalex.org/S4210185368","display_name":"Research and Practice in Thrombosis and Haemostasis","issn_l":"2475-0379","issn":["2475-0379"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Research and Practice in Thrombosis and Haemostasis","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10507376","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10507376","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10507376/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Res Pract Thromb Haemost","raw_type":"Text"},{"id":"pmid:37732158","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37732158","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Research and practice in thrombosis and haemostasis","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.1016/j.rpth.2023.102194","doi":"https://doi.org/10.1016/j.rpth.2023.102194","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rpth.2023.102194","pdf_url":null,"source":{"id":"https://openalex.org/S4210185368","display_name":"Research and Practice in Thrombosis and Haemostasis","issn_l":"2475-0379","issn":["2475-0379"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Research and Practice in Thrombosis and Haemostasis","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9907000064849854,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320310030","display_name":"Takeda Pharmaceuticals U.S.A.","ror":"https://ror.org/03bygaq51"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4386280355.pdf","grobid_xml":"https://content.openalex.org/works/W4386280355.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W1978543860","https://openalex.org/W2734287351","https://openalex.org/W2888898681","https://openalex.org/W2919343333","https://openalex.org/W2936143155","https://openalex.org/W2980900975","https://openalex.org/W3034586995","https://openalex.org/W3117329252","https://openalex.org/W3161962851","https://openalex.org/W3193629164"],"related_works":["https://openalex.org/W3034586995","https://openalex.org/W4403348208","https://openalex.org/W4417067162","https://openalex.org/W3197167619","https://openalex.org/W3193629164","https://openalex.org/W7221801921","https://openalex.org/W4407439626","https://openalex.org/W4412973857","https://openalex.org/W4401585054","https://openalex.org/W4417013674"],"abstract_inverted_index":{"Background:":[0],"Hemophilia":[1],"A":[2,64],"(HA)":[3],"is":[4,46,117],"a":[5,70,80],"genetic":[6],"bleeding":[7,78],"disorder":[8],"characterized":[9],"by":[10,90],"the":[11,14,95,101,108],"deficiency":[12],"of":[13,23,100,110],"coagulation":[15],"protein":[16],"factor":[17,29],"(F)":[18],"VIII":[19],"(FVIII).":[20],"The":[21,39,86],"development":[22],"neutralizing":[24],"antidrug":[25],"antibodies":[26],"(ADAs)":[27],"to":[28,42,106,112],"concentrates":[30],"(inhibitors)":[31],"created":[32],"an":[33],"unmet":[34],"need":[35,45],"for":[36],"novel":[37],"therapies.":[38],"first":[40,68],"agent":[41],"address":[43],"this":[44],"emicizumab.":[47,113],"Key":[48],"Clinical":[49,62],"Question:":[50],"Can":[51],"emicizumab":[52,116],"ADA":[53,111,137],"occur":[54],"in":[55,69],"patients":[56],"with":[57,74,139,142,151],"HA":[58,141,153],"without":[59,154],"FVIII":[60,92],"inhibitors?":[61],"Approach:":[63],"new":[65,149],"case":[66,150],"(the":[67],"noninhibitor":[71],"patient)":[72],"presented":[73],"unexpected":[75],"and":[76,79,94,120,144],"excessive":[77],"prolonged":[81],"activated":[82],"partial":[83],"thromboplastin":[84],"time.":[85],"patient":[87],"was":[88,104],"evaluated":[89],"assessing":[91],"levels,":[93],"previously":[96,134],"published":[97,135],"modified":[98],"version":[99],"Bethesda":[102],"assay":[103],"used":[105],"determine":[107],"level":[109],"Conclusion:":[114],"Although":[115],"very":[118],"effective":[119],"has":[121],"minimal":[122],"immunogenicity,":[123],"ADAs,":[124],"albeit":[125],"rare,":[126],"can":[127],"still":[128],"occur.":[129],"There":[130],"have":[131],"been":[132],"4":[133],"anti-emicizumab":[136],"cases":[138],"severe":[140,152],"inhibitors,":[143],"herein,":[145],"we":[146],"describe":[147],"1":[148],"inhibitors.":[155]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-08-31T00:00:00"}